(CEG) Constellation Energy - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US21037T1097
Stock: Electricity, Natural Gas, Renewables,
Total Rating 62
Risk 79
Buy Signal 0.08
| Risk 5d forecast | |
|---|---|
| Volatility | 55.1% |
| Relative Tail Risk | -14.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.83 |
| Alpha | 10.56 |
| Character TTM | |
|---|---|
| Beta | 1.714 |
| Beta Downside | 1.785 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.70% |
| CAGR/Max DD | 1.23 |
EPS (Earnings per Share)
Revenue
Description: CEG Constellation Energy March 05, 2026
Constellation Energy Corporation (CEG) is a U.S. energy company providing electricity, natural gas, and sustainable solutions. It operates across five segments: Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions.
The company maintains a generating capacity of approximately 31,676 megawatts, utilizing a diverse portfolio of nuclear, wind, solar, natural gas, and hydroelectric assets. Electric utilities, like Constellation, often manage a mix of generation sources to ensure grid stability and meet varying demand.
CEG serves a broad customer base, including utilities, municipalities, cooperatives, and commercial, industrial, public sector, and residential clients. This diversified customer base is typical for large energy providers.
For more in-depth analysis, consider researching CEGs performance on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 2.32b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 11.75 > 1.0 |
| NWC/Revenue: 16.35% < 20% (prev 16.68%; Δ -0.32% < -1%) |
| CFO/TA 0.07 > 3% & CFO 4.24b > Net Income 2.32b |
| Net Debt (5.24b) to EBITDA (5.79b): 0.91 < 3 |
| Current Ratio: 1.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (314.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 75.88% > 18% (prev 0.25%; Δ 7562 % > 0.5%) |
| Asset Turnover: 46.35% > 50% (prev 44.53%; Δ 1.82% > 0%) |
| Interest Coverage Ratio: 8.15 > 6 (EBITDA TTM 5.79b / Interest Expense TTM 511.0m) |
Altman Z'' 1.68
| A: 0.07 (Total Current Assets 12.12b - Total Current Liabilities 7.94b) / Total Assets 57.25b |
| B: 0.10 (Retained Earnings 5.90b / Total Assets 57.25b) |
| C: 0.08 (EBIT TTM 4.16b / Avg Total Assets 55.09b) |
| D: 0.34 (Book Value of Equity 14.52b / Total Liabilities 42.40b) |
| Altman-Z'' Score: 1.68 = BB |
Beneish M -3.55
| DSRI: 1.06 (Receivables 4.27b/3.72b, Revenue 25.53b/23.57b) |
| GMI: 0.33 (GM 75.88% / 25.39%) |
| AQI: 1.00 (AQ_t 0.40 / AQ_t-1 0.40) |
| SGI: 1.08 (Revenue 25.53b / 23.57b) |
| TATA: -0.03 (NI 2.32b - CFO 4.24b) / TA 57.25b) |
| Beneish M-Score: -3.55 (Cap -4..+1) = AAA |
What is the price of CEG shares?
As of March 05, 2026, the stock is trading at USD 322.85 with a total of 2,257,288 shares traded.
Over the past week, the price has changed by -0.92%, over one month by +28.90%, over three months by -12.42% and over the past year by +40.15%.
Over the past week, the price has changed by -0.92%, over one month by +28.90%, over three months by -12.42% and over the past year by +40.15%.
Is CEG a buy, sell or hold?
Constellation Energy has received a consensus analysts rating of 4.38.
Therefore, it is recommended to buy CEG.
- StrongBuy: 10
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CEG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 393.2 | 21.8% |
| Analysts Target Price | 393.2 | 21.8% |
CEG Fundamental Data Overview February 28, 2026
P/E Trailing = 43.6653
P/E Forward = 31.746
P/S = 4.591
P/B = 8.3053
P/EG = 3.6314
Revenue TTM = 25.53b USD
EBIT TTM = 4.16b USD
EBITDA TTM = 5.79b USD
Long Term Debt = 7.25b USD (from longTermDebt, last quarter)
Short Term Debt = 1.74b USD (from shortTermDebt, last quarter)
Debt = 8.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.24b USD (from netDebt column, last quarter)
Enterprise Value = 122.47b USD (117.22b + Debt 8.99b - CCE 3.75b)
Interest Coverage Ratio = 8.15 (Ebit TTM 4.16b / Interest Expense TTM 511.0m)
EV/FCF = 95.08x (Enterprise Value 122.47b / FCF TTM 1.29b)
FCF Yield = 1.05% (FCF TTM 1.29b / Enterprise Value 122.47b)
FCF Margin = 5.04% (FCF TTM 1.29b / Revenue TTM 25.53b)
Net Margin = 9.08% (Net Income TTM 2.32b / Revenue TTM 25.53b)
Gross Margin = 75.88% ((Revenue TTM 25.53b - Cost of Revenue TTM 6.16b) / Revenue TTM)
Gross Margin QoQ = none% (prev 23.72%)
Tobins Q-Ratio = 2.14 (Enterprise Value 122.47b / Total Assets 57.25b)
Interest Expense / Debt = 1.26% (Interest Expense 113.0m / Debt 8.99b)
Taxrate = 38.15% (264.0m / 692.0m)
NOPAT = 2.57b (EBIT 4.16b * (1 - 38.15%))
Current Ratio = 1.53 (Total Current Assets 12.12b / Total Current Liabilities 7.94b)
Debt / Equity = 0.62 (Debt 8.99b / totalStockholderEquity, last quarter 14.52b)
Debt / EBITDA = 0.91 (Net Debt 5.24b / EBITDA 5.79b)
Debt / FCF = 4.07 (Net Debt 5.24b / FCF TTM 1.29b)
Total Stockholder Equity = 13.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.21% (Net Income 2.32b / Total Assets 57.25b)
RoE = 16.78% (Net Income TTM 2.32b / Total Stockholder Equity 13.82b)
RoCE = 19.76% (EBIT 4.16b / Capital Employed (Equity 13.82b + L.T.Debt 7.25b))
RoIC = 11.45% (NOPAT 2.57b / Invested Capital 22.49b)
WACC = 11.41% (E(117.22b)/V(126.21b) * Re(12.23%) + D(8.99b)/V(126.21b) * Rd(1.26%) * (1-Tc(0.38)))
Discount Rate = 12.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.94%
[DCF] Terminal Value 63.79% ; FCFF base≈1.29b ; Y1≈1.13b ; Y5≈910.2m
[DCF] Fair Price = 13.25 (EV 10.05b - Net Debt 5.24b = Equity 4.80b / Shares 362.3m; r=11.41% [WACC]; 5y FCF grow -15.42% → 2.90% )
EPS Correlation: 74.93 | EPS CAGR: 69.21% | SUE: -0.01 | # QB: 0
Revenue Correlation: 5.35 | Revenue CAGR: -0.63% | SUE: 0.80 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.72 | Chg7d=-0.018 | Chg30d=-0.025 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-12-31): EPS=11.31 | Chg7d=-0.185 | Chg30d=-0.329 | Revisions Net=-4 | Growth EPS=+20.4% | Growth Revenue=+44.7%
EPS next Year (2027-12-31): EPS=13.52 | Chg7d=+0.067 | Chg30d=+0.003 | Revisions Net=-1 | Growth EPS=+19.6% | Growth Revenue=-21.2%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.9% (Discount Rate 12.2% - Earnings Yield 2.3%)
[Growth] Growth Spread = +22.6% (Analyst 32.6% - Implied 9.9%)
P/E Forward = 31.746
P/S = 4.591
P/B = 8.3053
P/EG = 3.6314
Revenue TTM = 25.53b USD
EBIT TTM = 4.16b USD
EBITDA TTM = 5.79b USD
Long Term Debt = 7.25b USD (from longTermDebt, last quarter)
Short Term Debt = 1.74b USD (from shortTermDebt, last quarter)
Debt = 8.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.24b USD (from netDebt column, last quarter)
Enterprise Value = 122.47b USD (117.22b + Debt 8.99b - CCE 3.75b)
Interest Coverage Ratio = 8.15 (Ebit TTM 4.16b / Interest Expense TTM 511.0m)
EV/FCF = 95.08x (Enterprise Value 122.47b / FCF TTM 1.29b)
FCF Yield = 1.05% (FCF TTM 1.29b / Enterprise Value 122.47b)
FCF Margin = 5.04% (FCF TTM 1.29b / Revenue TTM 25.53b)
Net Margin = 9.08% (Net Income TTM 2.32b / Revenue TTM 25.53b)
Gross Margin = 75.88% ((Revenue TTM 25.53b - Cost of Revenue TTM 6.16b) / Revenue TTM)
Gross Margin QoQ = none% (prev 23.72%)
Tobins Q-Ratio = 2.14 (Enterprise Value 122.47b / Total Assets 57.25b)
Interest Expense / Debt = 1.26% (Interest Expense 113.0m / Debt 8.99b)
Taxrate = 38.15% (264.0m / 692.0m)
NOPAT = 2.57b (EBIT 4.16b * (1 - 38.15%))
Current Ratio = 1.53 (Total Current Assets 12.12b / Total Current Liabilities 7.94b)
Debt / Equity = 0.62 (Debt 8.99b / totalStockholderEquity, last quarter 14.52b)
Debt / EBITDA = 0.91 (Net Debt 5.24b / EBITDA 5.79b)
Debt / FCF = 4.07 (Net Debt 5.24b / FCF TTM 1.29b)
Total Stockholder Equity = 13.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.21% (Net Income 2.32b / Total Assets 57.25b)
RoE = 16.78% (Net Income TTM 2.32b / Total Stockholder Equity 13.82b)
RoCE = 19.76% (EBIT 4.16b / Capital Employed (Equity 13.82b + L.T.Debt 7.25b))
RoIC = 11.45% (NOPAT 2.57b / Invested Capital 22.49b)
WACC = 11.41% (E(117.22b)/V(126.21b) * Re(12.23%) + D(8.99b)/V(126.21b) * Rd(1.26%) * (1-Tc(0.38)))
Discount Rate = 12.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.94%
[DCF] Terminal Value 63.79% ; FCFF base≈1.29b ; Y1≈1.13b ; Y5≈910.2m
[DCF] Fair Price = 13.25 (EV 10.05b - Net Debt 5.24b = Equity 4.80b / Shares 362.3m; r=11.41% [WACC]; 5y FCF grow -15.42% → 2.90% )
EPS Correlation: 74.93 | EPS CAGR: 69.21% | SUE: -0.01 | # QB: 0
Revenue Correlation: 5.35 | Revenue CAGR: -0.63% | SUE: 0.80 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.72 | Chg7d=-0.018 | Chg30d=-0.025 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-12-31): EPS=11.31 | Chg7d=-0.185 | Chg30d=-0.329 | Revisions Net=-4 | Growth EPS=+20.4% | Growth Revenue=+44.7%
EPS next Year (2027-12-31): EPS=13.52 | Chg7d=+0.067 | Chg30d=+0.003 | Revisions Net=-1 | Growth EPS=+19.6% | Growth Revenue=-21.2%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.9% (Discount Rate 12.2% - Earnings Yield 2.3%)
[Growth] Growth Spread = +22.6% (Analyst 32.6% - Implied 9.9%)